-
Eltrombopag Olamine CAS 496775-62-3Eltrombopag Olamine CAS 496775-62-3, is a thrombopoietin receptor agonist (TPO-RA) that stimulates the production of platelets. It is a small-molecule, non-peptide agonist that mimics the action...read more
-
Benserazide Hydrochloride CAS 14919-77-8Benserazide Hydrochloride CAS 14919-77-8, is a peripheral aromatic L-amino acid decarboxylase (AADC) inhibitor. It is not used as a standalone therapeutic agent but is almost exclusively combined...read more
-
Safinamide Mesylate CAS 202825-46-5Safinamide Mesylate CAS 202825-46-5, is a monoamine oxidase type B (MAO-B) inhibitor used for treatment of Parkinson's disease.read more
Indications: idiopathic Parkinson's disease (PD) as add-on... -
Tauroursodeoxycholic Acid CAS 14605 22 2Tauroursodeoxycholic Acid CAS 14605-22-2, is a naturally occurring hydrophilic tertiary bile acid, a combination of ursodeoxycholic acid (UDCA) and taurine.read more
Indications: It dissolves... -
Upadacitinib CAS 1310726-60-3Upadacitinib CAS 1310726-60-3, is an oral Janus kinase (JAK) inhibitor that selectively inhibits the JAK1 subtype and exerts anti-inflammatory effects by modulating immune...read more
-
Daridorexant Hcl CAS 1792993-84-0Daridorexant Hcl CAS 1792993-84-0, is a new type of oral dual orexin receptor antagonist (DORA) that helps patients fall asleep and maintain sleep by blocking the binding of the wake-promoting...read more
-
Trelagliptin Succinate CAS 1029877-94-8Trelagliptin Succinate CAS 1029877-94-8, is a dipeptidyl peptidase-4 (DPP-4) inhibitor, treatment of Type 2 Diabetes.read more
-
Vericiguat CAS 1350653-20-1Vericiguat CAS 1350653-20-1, is a soluble guanylate cyclase (sGC) stimulator, treatment of Heart Failure.read more
-
Viloxazine Hci CAS 35604-67-2Viloxazine Hcl CAS 35604-67-2, is a selective norepinephrine reuptake inhibitor (NRI), also exhibits activity as a 5-HT2C receptor agonist and a 5-HT2B receptor antagonist, treatment of Attention...read more
Eltrombopag. Eltrombopag is used to treat low blood platelet counts in adults with chronic immune (idiopathic) thrombocytopenia (ITP), when certain other medicines, or surgery to...
Eltrombopag olamine is approved to treat: Thrombocytopenia (low platelet levels). It is used in adults and in children aged 1 year or older with chronic immune thrombocytopenia (ITP). ITP is...
Hetrombopag olamine | C29H36N6O7 | CID 135565609 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities,...
This section was summarized by CADTH staff based on the input provided by patient groups. It has not been systematically reviewed. 1. Brief Description of Patient Group (S) Supplying Input....
Eltrombopag Olamine is the orally active ethanolamine salt of eltrombopag, a small-molecule, nonpeptide thrombopoietin receptor agonist with megakaryopoiesis-stimulating activity....
Eltrombopag is an inhibitor of OATP1B1 and BCRP transporters. Monitor patients closely for signs and symptoms of excessive exposure to the drugs that are substrates of OATP1B1 and BCRP...
